Patent Assignment
Reel/Frame 030062/0206
Change of Name
Recorded: 2013-03-21
Pages: 28
Assignor
NYCOMED GMBH
Executed: 2012-11-14
Assignee
TAKEDA GMBH
BYK-GULDEN-STRASSE 2, KONSTANZ, 78467, GERMANY
Covered Properties
(29)
Oral-Admininistration Forms of a Medicament Containing Pantoprazol
Patent:
5,997,903 →
Application:
08/167,961 →
Oral Pharmaceutical Composition with Delayed Release of Active Ingredient for Pantoprazole
Patent:
5,945,124 →
Application:
08/498,386 →
Prednisolone Derivatives
Patent:
5,733,901 →
Application:
08/530,173 →
Novel Silyl Compounds and Their Use
Patent:
5,728,826 →
Application:
08/704,574 →
Synthetic Peptide Analogs of Lung Surface Protein Sp-C
Patent:
5,874,406 →
Application:
08/750,194 →
Dihydrobenzofurans
Patent:
6,121,274 →
Application:
08/750,920 →
Compositions for Treating Irds and Ards with a Combination of a Glucocorticosteroid and a Lung Surfactant, and Their Use
Patent:
5,891,844 →
Application:
08/809,687 →
Screening Kit and Process for Determining Action of Substances Inhibiting the P-Type Atpase Activity of Helicobacter Pylori
Patent:
5,981,184 →
Application:
08/849,480 →
Oral Pharmaceutical Composition with Delayed Release of Active Ingredient for Pantoprazole
Patent:
6,068,856 →
Application:
09/042,090 →
Process for the Production of Powdered Pulmonary Surfactant Preparations
Patent:
6,315,983 →
Application:
09/117,142 →
Novel Phenanthridines Substituted in the 6 Position
Patent:
6,127,378 →
Application:
09/142,206 →
Novel Benzofuran-4-Carboxamides
Patent:
6,211,203 →
Application:
09/147,640 →
Process for R-Epimer Enrichment of 16,17-Acetal Derivatives of 21-Acyloxy Pregna-1,4-Dien-11.Beta. , 16.Alpha. , 17.Alpha.-Triol-3,20-Dione Derivatives
Patent:
6,787,533 →
Application:
09/147,675 →
Novel Benzonaphthyridines
Patent:
6,008,215 →
Application:
09/284,458 →
Synergistic Combination of Pde Inhibitors and Adenylate Cyclase Agonists or Guanyl Cyclyse Agonists
Patent:
6,333,354 →
Application:
09/367,850 →
Compositions for the Treatment of Ards or Irds Containing 3- (Cyclopropylmethoxy) -N- (3,5-Dichloro-4-Pyridinyl) -4- (Difluoromethoxy) Benzamide and Lung Surfactant
Patent:
6,436,970 →
Application:
09/369,455 →
Oral Pharmaceutical Composition with Delayed Release of Active Ingredient for Pantoprazole
Patent:
6,274,173 →
Application:
09/461,388 →
Novel Compositions
Stabilized Pharmaceutical Product
Ciclesonide containing sterile aqueous suspension
Stabilized Pharmaceutical Product
SUBSTITUTED 7-CARBOXAMIDO-PYRROLO[3,2-d]PYRIMIDINES
Novel Pyrazolone-Derivatives and Their Use as Pde-4 Inhibitors
Stabilized Pharmaceutical Product
Apparatus for the Aerosolization of Large Volumes of Dry Powder
Methylpyrrolopyrimidinecarboxamides
Methylpyrrolopyridinecarboxamides
Stabilized Pharmaceutical Product
3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4,3-c] ISOQUINOLINE DERIVATIVES
Related Assignments
(18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 9, 2011
From: SCHLEMMINGER, IMRE; SCHMIDT, BEATE; FLOCKERZI, DIETER; TENOR, HERMANN
To: NYCOMED GMBH
Reel/Frame 026245/0873 →
Merger
Jul 28, 2015
From: NYCOMED ASSET MANAGEMENT GMBH
To: NYCOMED GERMANY HOLDING GMBH
Reel/Frame 036201/0261 →
Merger
Jul 28, 2015
From: TAKEDA GMBH
To: NYCOMED ASSET MANAGEMENT GMBH
Reel/Frame 036193/0178 →
Change of Name
Jul 29, 2015
From: NYCOMED GERMANY HOLDING GMBH
To: TAKEDA GMBH
Reel/Frame 036205/0192 →
Assignment of Assignor's Interest
Jan 11, 2017
From: TAKEDA GMBH
To: ASTRAZENECA AB
Reel/Frame 041328/0362 →
Assignment of Assignor's Interest
Dec 10, 2018
From: ASTRAZENECA AB
To: COVIS PHARMA B.V.
Reel/Frame 047761/0435 →
Security Interest
Dec 20, 2018
From: COVIS PHARMA B.V.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 047834/0926 →
Security Interest
Mar 12, 2020
From: COVIS PHARMA B.V.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 052095/0262 →
Release of Security Interest
Mar 17, 2020
From: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: COVIS PHARMA B.V.
Reel/Frame 052142/0961 →
Business Transfer and Contribution Agreement
Dec 16, 2020
From: COVIS PHARMA B.V.
To: COVIS PHARMA GMBH
Reel/Frame 054793/0416 →
Security Interest
Feb 22, 2021
From: COVIS PHARMA GMBH
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 055354/0063 →
Notice of Grant of Security Interest in Intellectual Property (First Lien)
Jan 4, 2022
From: COVIS PHARMA GMBH
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 058640/0787 →
Release of Security Interest
Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA B.V.
Reel/Frame 059043/0239 →
Notice of Grant of Security Interest in Intellectual Property (Second Lien)
Feb 18, 2022
From: COVIS PHARMA GMBH
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 059232/0514 →
Release of Security Interest
Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA GMBH
Reel/Frame 059043/0226 →
Release of Security Interest
Jun 2, 2023
From: BARCLAYS BANK PLC
To: COVIS PHARMA GMBH
Reel/Frame 063841/0208 →
Release of Security Interest in Patents
Mar 17, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: COVIS PHARMA GMBH
Reel/Frame 070537/0122 →
Confirmatory Grant of Security Interest in United States Patents
May 27, 2025
From: COVIS PHARMA GBMH
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 071409/0368 →